Measuring how tumors react to cancer treatment plays a major role in determining a patient��s outcome. The process, normally performed by trained radiologists, is labor-intensive, subjective and prone to inconsistency. To help alleviate the problem, researchers at the National Institutes of Health, the Ping An Insurance company, and a researcher presently at NVIDIA developed a deep learning-based��
]]>